Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bediol and oxycodone for fibromyalgia pain
NL-OMON26860Recruiting
- Sponsor
- Investigator-Initiated
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in fibromyalgia (FM) comparing Oxycodone, Bediol + oxycodone and Bediol (3 arms). Primary endpoint: Composite side effects score. Started Jul 2019; status: recruiting.
02
Drugs
bedioloxycodone
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NL-OMON26860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26860.